At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled / 44 target
Drug / intervention
Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of The Erchonia® PPL Laser as a Pre-Treatment Adjunct to Enhance Standard Erchonia Red Laser Therapy for the Temporary Relief of Nociceptive Musculoskeletal Pain
In Brief
A clinical study evaluating Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy for Musculoskeletal Pain. Completed, enrolled 44 participants across 1 site.
Signals
Enrolling ahead of pace
Detailed Summary
This study is to see if applying pre-treatment with the Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy can help reduce nociceptive musculoskeletal pain
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMusculoskeletal Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2026
First PostedAug 2025
Enrollment StartAug 2025
Primary CompletionMar 2026
Study CompletionMar 2026
TodayJul 2026
First PostedAug 14, 2025
Enrollment StartAug 20, 2025
Primary CompletionMar 26, 2026
Study CompletionMar 28, 2026
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11 months ago
Arms & Interventions
Erchonia® PPLexperimental
Device: Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy
Interventions
Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapydevice
450 nanometers (nm) blue dual-diode laser application followed by 640nm red laser application